Pharmaceutical Packaging Market size to cross USD 744.6 billion by 2035

The global pharmaceutical packaging market was valued at USD 172.6 billion in 2025 and is estimated to grow at a CAGR of 15.9% to reach USD 744.6 billion in 2035, as per the latest report published by Global Market Insights Inc.

Stringent Regulations on Drug Safety

Increasingly strict regulations related to drug safety and quality assurance are significantly driving the growth of the pharmaceutical testing and compliance market. Regulatory authorities across the world are implementing rigorous guidelines to ensure that pharmaceutical products are safe, effective, and meet high-quality standards before reaching consumers. Pharmaceutical companies are required to conduct extensive testing procedures, including toxicity testing, stability testing, microbial testing, and quality control assessments throughout the drug development and manufacturing process. In addition, rising concerns regarding counterfeit drugs, product recalls, and adverse drug reactions have encouraged manufacturers to adopt advanced testing technologies and comply with international regulatory frameworks.

Aging Population and Chronic Disease

The growing aging population and rising prevalence of chronic diseases are major factors contributing to the expansion of healthcare and pharmaceutical industries. Elderly individuals are more susceptible to long-term health conditions such as cardiovascular diseases, diabetes, cancer, respiratory disorders, and neurological illnesses, resulting in increased demand for medicines, therapies, and medical treatments. This growing patient population is driving pharmaceutical companies to develop new drugs and treatment solutions, thereby increasing the need for clinical trials, diagnostic services, and pharmaceutical testing. Additionally, advancements in healthcare infrastructure and improved access to medical services are supporting the management of chronic diseases among aging populations worldwide. Governments and healthcare organizations are also increasing investments in healthcare systems and drug development programs to address the rising burden of chronic illnesses, further supporting market growth.

Material Fragility and Handling Risks

Material fragility and handling risks represent a significant challenge across industries such as packaging, pharmaceuticals, electronics, logistics, and healthcare. Many products, especially those made of glass, thin plastics, or delicate composite materials, are highly sensitive to physical impact, vibration, pressure, and temperature changes during manufacturing, storage, and transportation. This makes them more prone to breakage, deformation, or performance degradation if not handled properly. In pharmaceutical and healthcare packaging, for instance, vials, ampoules, and syringes require extremely careful handling to maintain sterility and prevent contamination or leakage. Even minor damage can compromise product safety and lead to financial losses, product recalls, or regulatory non-compliance.

Browse key industry insights spread across 180 pages with 767 market data tables and figures from the report, “Pharmaceutical Packaging  Market Size - By Packaging Type (Primary Packaging, Secondary Packaging, Tertiary Packaging), By Packaging Format (Rigid Packaging, Semi-Rigid Packaging, Flexible Packaging), By Material Type (Plastics, Glass, Aluminum, Paper & Paperboard, Others), By Functionality (Conventional Packaging, Sterile Packaging, Child-Resistant & Tamper-Evident Packaging, Serialization-Enabled Packaging, Temperature-Controlled Packaging – Cold Chain), By Drug Form (Solid Dosage, Liquid/Injectable, Biologics & Biosimilars, Dermal & Topical, Ophthalmic, Pulmonary/Inhalation, Others), By End User (Pharmaceutical Manufacturers, Contract Manufacturing, Hospitals & Healthcare Facilities, Retail Pharmacies).” in detail, along with the table of contents: https://www.gminsights.com/industry-analysis/pharmaceutical-packaging-market

Primary Packaging to Gain Traction

The primary packaging segment accounted for a 70.4% share of pharmaceutical packaging market in 2025. The segment’s growth is primarily driven by the increasing demand for injectables, biologics, vaccines, and oral liquid formulations that require secure, sterile, and chemically stable packaging solutions in direct contact with pharmaceutical products. Packaging formats such as vials, ampoules, prefilled syringes, blister packs, and bottles play a crucial role in maintaining drug integrity, ensuring patient safety, and meeting stringent regulatory standards. Furthermore, the growing adoption of ready-to-use packaging solutions and advanced barrier technologies is further supporting the expansion and dominance of the primary packaging segment globally.

Rising Growth of Contract Manufacturing Organizations (CMOs)

The contract manufacturing organizations (CMOs) segment of pharmaceutical packaging market is projected to grow at a CAGR of 16.8% through 2035. The increasing preference among pharmaceutical companies for outsourcing manufacturing and packaging operations to CMOs is a major factor driving segment growth. Outsourcing enables pharmaceutical manufacturers to achieve cost efficiency, operational scalability, and improved regulatory compliance. CMOs are increasingly adopting ready-to-use primary packaging solutions, flexible and rigid packaging formats, and serialized secondary packaging systems to enhance supply chain efficiency and comply with evolving regulatory requirements. The rising focus on streamlined production and specialized pharmaceutical packaging solutions is expected to further accelerate the growth of this segment.

North America as a Propelling Region

North America pharmaceutical packaging market accounted for 35.3% share in 2025, supported by the region’s strong focus on advanced, sustainable, and regulation-compliant packaging solutions. Pharmaceutical manufacturers across the region are increasingly utilizing high-quality glass, rigid plastics, and flexible packaging materials integrated with barrier coatings, tamper-evident features, and prefilled delivery systems to ensure drug stability, sterility, and patient safety. The growing production of injectables, biologics, specialty drugs, and vaccines is significantly contributing to packaging demand in the region. Additionally, government initiatives promoting sustainable packaging materials and serialization standards are further driving the adoption of high-performance pharmaceutical packaging solutions across both primary and secondary packaging applications.

Prominent players operating in the global pharmaceutical packaging market include Alpla Group, Amcor plc, AptarGroup, Inc., Becton, Dickinson and Company (BD), Bormioli Pharma, CCL Industries Inc., Comar LLC, Datwyler Holding Inc., Gerresheimer AG, Huhtamaki Oyj, Nipro Corporation, Origin Pharma Packaging, Schott AG, SCHOTT Kaisha Private Limited, SGD Pharma, Stevanato Group S.p.A., and West Pharmaceutical Services, Inc..

Leading companies in the pharmaceutical packaging market are focusing on several strategic initiatives to strengthen their market presence and enhance competitive positioning. Major players are heavily investing in research and development activities to introduce innovative packaging solutions with advanced barrier properties, tamper-evident features, and sustainable materials. Companies are also emphasizing the development of ready-to-use and prefilled packaging systems to address the increasing demand for biologics, injectables, and specialty drugs. Strategic collaborations, mergers, and acquisitions are widely adopted to expand technological capabilities, strengthen product portfolios, and enhance geographic reach.

In February 2025, Plastic Ingenuity developed a polyester-based thermoform-ready tub for the pharmaceutical packaging market to meet the growing demand for sustainable packaging solutions. The company focused on reducing environmental impact and addressing concerns related to plastic waste across the European market.